Nicolas Roussot

6PUBLICATIONS
12CO-AUTHORS
ChemotherapyMolecular targetsPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 21, 2025
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer.

Anaïs Perrichet, Julie Lecuelle, Emeric Limagne

|Mar 13, 2025
Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies.

Nicolas Roussot, Courèche Kaderbhai, François Ghiringhelli

|Oct 27, 2023
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report.

Nicolas Roussot, Julie Lecuelle, Lorraine Dalens

|Nov 26, 2022
Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment.

Nicolas Roussot, François Ghiringhelli, Cédric Rébé

Pageof 1